119 related articles for article (PubMed ID: 7504533)
21. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
Durocher Y; Chapdelaine A; Chevalier S
Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
[TBL] [Abstract][Full Text] [Related]
22. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.
Amaral MC; Miles S; Kumar G; Nel AE
J Clin Invest; 1993 Aug; 92(2):848-57. PubMed ID: 7688764
[TBL] [Abstract][Full Text] [Related]
23. Hierarchical phosphorylation of a 50-kDa protein by protein tyrosine kinases TPK-IIB and C-Fgr, and its identification as HS1 hematopoietic-lineage cell-specific protein.
Brunati AM; Ruzzene M; James P; Guerra B; Pinna LA
Eur J Biochem; 1995 Apr; 229(1):164-70. PubMed ID: 7744027
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine protein kinases and their substrates in human leukemia cells.
Wickremasinghe RG; Piga A; Mire AR; Taheri MR; Yaxley JC; Hoffbrand AV
Leuk Res; 1985; 9(12):1443-50. PubMed ID: 4079454
[TBL] [Abstract][Full Text] [Related]
25. Spleen protein tyrosine kinases TPK-IIB and CSK display different immunoreactivity and opposite specificities toward c-src-derived peptides.
Brunati AM; Allee G; Marin O; Donella-Deana A; Cesaro L; Bougeret C; Fagard R; Benarous R; Fischer S; Pinna LA
FEBS Lett; 1992 Nov; 313(3):291-4. PubMed ID: 1280230
[TBL] [Abstract][Full Text] [Related]
26. Selective effect of poly(lysine) on the enhancement of the lyn tyrosine protein kinase activity. Increased specificity toward src peptides.
Donella-Deana A; Marin O; Brunati AM; Pinna LA
Eur J Biochem; 1992 Mar; 204(3):1159-63. PubMed ID: 1372554
[TBL] [Abstract][Full Text] [Related]
27. Substitution of phosphotyrosine for sulphotyrosine in biologically active peptides. Enzymatic phosphorylation of a progastrin peptide confers immunoreactivity reminiscent of the sulphated derivative.
Donella-Deana A; Varro A; Dockray GJ; Pinna LA
Biochim Biophys Acta; 1991 Oct; 1095(1):75-7. PubMed ID: 1718435
[TBL] [Abstract][Full Text] [Related]
28. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.
Wildenhain Y; Pawson T; Blackstein ME; Andrulis IL
Oncogene; 1990 Jun; 5(6):879-83. PubMed ID: 1694290
[TBL] [Abstract][Full Text] [Related]
29. Exogenous phosphotyrosine modulates epidermal growth factor receptor tyrosine phosphorylation.
Mishra S; Hamburger AW
Carcinogenesis; 1993 Feb; 14(2):269-73. PubMed ID: 7679612
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
Salh B; Marotta A; Matthewson C; Ahluwalia M; Flint J; Owen D; Pelech S
Anticancer Res; 1999; 19(1B):731-40. PubMed ID: 10216485
[TBL] [Abstract][Full Text] [Related]
31. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases.
Eiseman E; Bolen JB
Nature; 1992 Jan; 355(6355):78-80. PubMed ID: 1370575
[TBL] [Abstract][Full Text] [Related]
32. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
33. [Tyrosine-phosphorylated proteins in human breast carcinoma].
Bretti S; Cappa AP; Comoglio PM; Di Renzo MF
J Nucl Med Allied Sci; 1990; 34(4 Suppl):205-10. PubMed ID: 1709208
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylated residues as specificity determinants for an acidophilic protein tyrosine kinase. A study with src and cdc2 derived phosphopeptides.
Donella-Deana A; Marin O; Brunati AM; Cesaro L; Piutti C; Pinna LA
FEBS Lett; 1993 Sep; 330(2):141-5. PubMed ID: 7689979
[TBL] [Abstract][Full Text] [Related]
35. The spleen protein-tyrosine kinase TPK-IIB is highly similar to the catalytic domain of p72syk.
Brunati AM; James P; Guerra B; Ruzzene M; Donella-Deana A; Pinna LA
Eur J Biochem; 1996 Sep; 240(2):400-7. PubMed ID: 8841405
[TBL] [Abstract][Full Text] [Related]
36. Specificity determinants for tyrosine protein kinase. A study with recombinant hirudin mutants.
Donella-Deana A; Stone SR; Pinna LA
Eur J Biochem; 1991 Oct; 201(2):501-5. PubMed ID: 1935946
[TBL] [Abstract][Full Text] [Related]
37. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer.
Huang J; Bay BH; Tan PH
Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine phosphorylation and activation of mitogen-activated protein kinase in the rat brain following transient cerebral ischemia.
Hu BR; Wieloch T
J Neurochem; 1994 Apr; 62(4):1357-67. PubMed ID: 7510779
[TBL] [Abstract][Full Text] [Related]
39. [The effects of genistein on tyrosine protein kinase-mitogen activated protein kinase signal transduction pathway in hypertrophic scar fibroblasts].
Cao C; Li SR; Dai X; Chen YQ; Feng Z; Qin X; Zhao Y; Wu J
Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):118-21. PubMed ID: 18785412
[TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer.
Ottenhoff-Kalff AE; van Oirschot BA; Hennipman A; de Weger RA; Staal GE; Rijksen G
Breast Cancer Res Treat; 1995 Mar; 33(3):245-56. PubMed ID: 7749152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
